U.S. Direct Anterior Approach (Total Hip Replacement) Market in ACS Market Research Report, by U.S. Total Hip Replacement Market, U.S. Total Hip Replacement by DAA, U.S. Total Hip Replacement Market for DAA by ACS - Global Forecast Till 2023

Introduction
Direct anterior approach is a type of hip replacement surgery. It is a minimally invasive surgical technique. In this approach, a 3 to 4-inch incision is made on the front of the hip which allows the joint to be replaced by moving muscles aside along their natural tissue planes, without detaching any tendons. The technique is useful for a quick recovery with less pain and normal functioning after hip replacement. The growing prevalence of osteoarthritis, rising geriatric population, rising R&D by Key Players of the market, and favorable reimbursement policies are expected to drive the market growth. According to the Arthritis Foundation in 2017, about 30.8 million adults residing within the US were reported to suffer from osteoarthritis. However, the high cost of total hip arthroplasty and incidences of product recalls may hamper the growth of the market.
The US direct anterior approach market is expected to reach a market value of USD 23,129.1 million by 2023 from USD 16,838 million in 2017 and is expected to register a CAGR of 5.4% during the forecast period from 2018 to 2023.
The US direct anterior approach market is segmented by a number of procedures and ambulatory surgical centers.
Key Players
Johnson & Johnson Services Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Smith & Nephew, OrthAlign, Inc., Proliance Surgeons, The Hip and Knee Center, Centre for Special Surgery, Bone & Joint Surgery Clinic, and Orthoillinois.
Study Objectives
To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the US direct anterior approach market
To provide insights into factors affecting the market growth
To analyze the US direct anterior approach market based on various tools such as supply chain analysis and Porters five force analysis
To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
To provide country-level analysis of the market with respect to current market size and future perspective
To provide country-level analysis of the market for segments by the number of procedures and ambulatory surgical centers
To provide strategic profiling of Key Players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the US direct anterior approach market
Target Audience
Potential Investors
Hospitals and Clinics
Government Associations
Pharmaceutical & Biotechnology Industries
Research Institutes
Suppliers and Distributors
Raw Material Suppliers
Key Findings
The US direct anterior approach market is expected to reach USD 23,129.1 million by 2023 at a CAGR of 5.4 % from 2018 to 2023
On the basis of the number of procedures, the market is expected to register a CAGR of 6.1% by 2023
On the basis of ambulatory surgical centers, the market is expected to register a CAGR of 13.6% by 2023


1Report Prologue
2 Market Introduction
2.1Introduction
2.2Assumptions & Limitations
3 Research Methodology
3.1Research Process
3.2Primary Research
3.3Secondary Research
3.4Market Size Estimation
4Market Dynamics
4.1Introduction
4.2Drivers
4.2.1Increasing prevalence osteoarthritis
4.2.2Growing geriatric population
4.2.3Rising R&D by the key players of the market
4.2.4Favourable reimbursement policies
4.2.5Drivers Impact Analysis
4.3Restraints
4.3.1High cost of total hip arthroplasty
4.3.2Incidence of product recalls
4.3.3Restraints Impact Analysis
4.4Opportunity
4.4.1Rising demands for the minimally invasive surgical procedures
4.5Macroeconomic Indicator
4.6Product Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS
4.7Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS
5Market Factor Analysis
5.1Value Chain Analysis
5.1.1R&D and Designing
5.1.2Manufacturing
5.1.3Distribution & Sales
5.1.4Post-Sales Review
5.2Porters Five Forces Model
5.2.1Bargaining Power of Suppliers
5.2.1Bargaining Power of Buyers
5.2.2Threat of New Entrants
5.2.3Threat of Substitutes
5.2.4Intensity of Rivalry
5.3Investment Opportunities
5.4Pricing Analysis
5.5Demand & Supply: Gap Analysis
6U.S Direct Anterior Approach (Total Hip Replacement) Market
6.1Total Hip Replacement
6.1.1Total Hip Replacement by DAA (Direct anterior approach)
7Competitive Landscape
7.1Competitive Landscape
7.1.1Ambulatory Surgical Centers
7.1.1.1Introduction
7.1.2Product Mapping
8Company Profile
8.1Johnson & Johnson Services Inc. (DePuy Synthes)
8.1.1Company Overview
8.1.2Financial Overview
8.1.3Products Offering
8.1.4Key Developments
8.1.5SWOT Analysis
8.1.6Key Strategy
8.2Stryker
8.2.1Company Overview
8.2.2Financial Overview
8.2.3Products Offering
8.2.4Key Developments
8.2.5SWOT Analysis
8.2.6Key Strategy
8.3Zimmer Biomet
8.3.1Company Overview
8.3.2Financial Overview
8.3.3Products Offering
8.3.4Key Developments
8.3.5SWOT Analysis
8.3.6Key Strategy
8.4Smith & Nephew
8.4.1Company Overview
8.4.2Financial Overview
8.4.3Products Offering
8.4.4Key Developments
8.4.5SWOT Analysis
8.4.6Key Strategy
8.5OrthAlign, Inc.
8.5.1Company Overview
8.5.2Financial Overview
8.5.3Products Offering
8.5.4Key Developments
8.5.5SWOT Analysis
8.5.6Key Strategy
8.6Proliance Surgeons
8.6.1Company Overview
8.6.2Financial Overview
8.6.3Products Offering
8.6.4Key Developments
8.6.5SWOT Analysis
8.6.6Key Strategy
8.7The Hip and knee center
8.7.1Company Overview
8.7.2Financial Overview
8.7.3Products Offering
8.7.4Key Developments
8.7.5SWOT Analysis
8.7.6Key Strategy
8.8Centre for Special Surgery
8.8.1Company Overview
8.8.2Financial Overview
8.8.3Products Offering
8.8.4Key Developments
8.8.5SWOT Analysis
8.8.6Key Strategy
8.9Bone & Joint Surgery Clinic
8.9.1Company Overview
8.9.2Financial Overview
8.9.3Products Offering
8.9.4Key Developments
8.9.5SWOT Analysis
8.9.6Key Strategy
8.1Orthoillinois
8.10.1Company Overview
8.10.2Financial Overview
8.10.3Products Offering
8.10.4Key Developments
8.10.5SWOT Analysis
8.10.6Key Strategy
9Conclusion
9.1Key Findings
9.1.1From CEOs View Point
9.2Key Companies and Surgical Ambulatory Centers to Watch

List Of Tables



TABLE 1U.S. TOTAL HIP REPLACEMENT MARKET 2015-2023 (USD MILLION)
TABLE 2U.S. TOTAL HIP REPLACEMENT MARKET, BY NUMBER OF PROCEDURE 2012-2015
TABLE 3U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2015-2023 (USD MILLION)
TABLE 4U.S. TOTAL HIP REPLACEMENT BY DAA, NUMBER OF PROCEDURE 2014-2017 (USD MILLION)
TABLE 5U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS ASC 2015-2023 (USD MILLION)
TABLE 6TOP 3 U.S. AMBULATORY SURGICAL CENTER FOR THR (2016)

List Of Figures



FIGURE 1RESEARCH PROCESS
FIGURE 2DROC ANALYSIS OF THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC
FIGURE 3DRIVERS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET
FIGURE 4RESTRAINTS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET
FIGURE 5VALUE CHAIN: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET
FIGURE 6PORTERS FIVE FORCES MODEL: THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC
FIGURE 7U.S. TOTAL HIP REPLACEMENT MARKET 2015 - 2023 (USD MILLION)
FIGURE 8U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2015 - 2023 (USD MILLION)
FIGURE 9U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS 2015 - 2023 (USD MILLION)
FIGURE 10U.S. TOTAL HIP REPLACEMENT, MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2017 (%)

2019 U.S. Infectious Diseases: Supplier Shares and Sales Segment Forecasts--Hospitals, Labs, Blood Banks, POC Locations

Complete report $11,500.  DataPack  (test volumes, sales forecasts, supplier shares) $7,500. new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during

USD 9500 View Report

2019 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available